Back

Anticoagulation for cancer-associated venous thromboembolism: navigating between risks of recurrence and bleeding

European Heart Journal

5 September 2025
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR DISEASE IN SPECIFIC POPULATIONS

Contributors

Sabine Eichinger
Sabine Eichinger

Author

Paul A Kyrle
Paul A Kyrle

Author

You may be interested in
thumbnail
Congress Presentation
Comparative characteristics of anticoagulants used in cancer-associated thrombosis
20 June 2025
thumbnail
Congress Session
Bridging worlds in stroke prevention: finding consensus between healthcare professionals for complex atrial fibrillation scenarios
31 August 2025
thumbnail
Congress Session
Don’t forget to look right
18 May 2025
thumbnail
Congress Presentation
Comparison of apixaban 5 mg vs 2.5 mg for the prevention of cancer-associated venous thromboembolism: A pooled analysis of two studies
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources